eventscribe

The eventScribe Educational Program Planner system gives you access to information on sessions, special events, and the conference venue. Take a look at hotel maps to familiarize yourself with the venue, read biographies of our plenary speakers, and download handouts and resources for your sessions.

close this panel

SUBMIT FEEDBACKfeedback icon

Comments


close this panel
support

Technical Support


Phone: (410) 638-9239

Fax: (410) 638-6108

GoToMeeting: Meet Now!

Web: www.CadmiumCD.com

Submit Support Ticket

t on the system-->

close this panel
‹‹ Go Back

Lev S. Sverdlov

Redmond Analytics LLC



�� Go Back

Please enter your access key

The asset you are trying to access is locked for premium users. Please enter your access key to unlock.


Email This Presentation:

From:

To:

Subject:

Body:

←Back IconGems-Print

73 – Model Diagnostics, Model Selection, and Their Applications to Advanced Data Analysis

Increased Chance for Recovery vs. Risk Reduction

Sponsor: Health Policy Statistics Section
Keywords: Chance for recovery, Risk reduction, Sensitivity to treatment, Spontaneous recovery, Biomarkers, Hidden variable

Lev S. Sverdlov

Redmond Analytics LLC

Indices of risk reduction are commonly used to assess the effectiveness of treatment. Increase in chance of recovery is a logically equivalent counterpart to risk reduction. The recovery model emphasizes the distinction between capability of spontaneous recovery and sensitivity to compared treatments. Exploiting this may help improve prediction of treatment response, facilitate search for biomarkers, and reduce risk for adverse effects via eliminating unnecessary prescriptions. Spontaneous and treatment-induced recoveries are not phenotypically distinguishable; thus we introduce a hidden variable model. The (unobservable) proportion of patients sensitive to treatment is not equal to the (observable) proportion of "responders"; we introduce a logical framework for this relationship, which constrains the priors for Bayesian analysis. Clinical, experimental, and epidemiological data will be presented to motivate the hidden variable architecture. We focus on the interface between the clinical and statistical aspects of effectiveness assessment, and on the development of a conceptual, structural, and logical framework.

"eventScribe", the eventScribe logo, "CadmiumCD", and the CadmiumCD logo are trademarks of CadmiumCD LLC, and may not be copied, imitated or used, in whole or in part, without prior written permission from CadmiumCD. The appearance of these proceedings, customized graphics that are unique to these proceedings, and customized scripts are the service mark, trademark and/or trade dress of CadmiumCD and may not be copied, imitated or used, in whole or in part, without prior written notification. All other trademarks, slogans, company names or logos are the property of their respective owners. Reference to any products, services, processes or other information, by trade name, trademark, manufacturer, owner, or otherwise does not constitute or imply endorsement, sponsorship, or recommendation thereof by CadmiumCD.

As a user you may provide CadmiumCD with feedback. Any ideas or suggestions you provide through any feedback mechanisms on these proceedings may be used by CadmiumCD, at our sole discretion, including future modifications to the eventScribe product. You hereby grant to CadmiumCD and our assigns a perpetual, worldwide, fully transferable, sublicensable, irrevocable, royalty free license to use, reproduce, modify, create derivative works from, distribute, and display the feedback in any manner and for any purpose.

© 2015 CadmiumCD